These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8896538)

  • 21. Varicella-zoster virus: Prevention through vaccination.
    Gnann JW
    Clin Obstet Gynecol; 2012 Jun; 55(2):560-70. PubMed ID: 22510639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and control of varicella-zoster infections in healthcare facilities.
    Weber DJ; Rutala WA; Hamilton H
    Infect Control Hosp Epidemiol; 1996 Oct; 17(10):694-705. PubMed ID: 8899447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella-zoster virus infection in Australia.
    Chant KG; Sullivan EA; Burgess MA; Ferson MJ; Forrest JM; Baird LM; Tudehope DI; Tilse M
    Aust N Z J Public Health; 1998 Jun; 22(4):413-8. PubMed ID: 9659764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean--a systematic review and meta-analysis.
    Bardach A; Cafferata ML; Klein K; Cormick G; Gibbons L; Ruvinsky S
    Pediatr Infect Dis J; 2012 Dec; 31(12):1263-8. PubMed ID: 23188098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Investigation on sera prevalence rate of varicella and immunogenicity of varicella vaccine in healthy children].
    Zhou T; Wang J; Qiu P
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Oct; 19(5):271-3. PubMed ID: 10322684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on trends in varicella mortality during the varicella vaccine era-United States, 1990-2016.
    Leung J; Marin M
    Hum Vaccin Immunother; 2018; 14(10):2460-2463. PubMed ID: 29939802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiologic lessons: chickenpox outbreak investigation in a rural community around Chandigarh, North India.
    Singh MP; Singh G; Kumar A; Singh A; Ratho RK
    Indian J Pathol Microbiol; 2011; 54(4):772-4. PubMed ID: 22234108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
    Sauerbrei A; Wutzler P
    J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Summary of the multidisciplinary guideline 'Varicella'].
    Rothbarth PH; Hartwig NG; Opstelten W
    Ned Tijdschr Geneeskd; 2011; 155(51):A3511. PubMed ID: 22200141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness over time of varicella vaccine.
    Vázquez M; LaRussa PS; Gershon AA; Niccolai LM; Muehlenbein CE; Steinberg SP; Shapiro ED
    JAMA; 2004 Feb; 291(7):851-5. PubMed ID: 14970064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
    Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination.
    Avila-Aguero ML; Ulloa-Gutierrez R; Camacho-Badilla K; Soriano-Fallas A; Arroba-Tijerino R; Morice-Trejos A
    Expert Rev Vaccines; 2017 Mar; 16(3):229-234. PubMed ID: 27786560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
    Wen SY; Liu WL
    Pediatrics; 2015 Mar; 135(3):e565-71. PubMed ID: 25713285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical benefits of routine varicella vaccination for adults.
    Germinario C; Gallone MS; Cappelli MG; Tafuri S
    Hum Vaccin Immunother; 2015; 11(6):1426-8. PubMed ID: 25970524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.